First released in 2019, the Society for Cardiovascular Angiography and Interventions (SCAI) cardiogenic shock categories have gotten a rethink, one that adds nuance to aid decision-making and ...

Please provide your email address to receive an email when new articles are posted on . The SCAI shock classification system may provide mortality risk stratification of patients at risk for or who ...

Istaroxime has previously completed two positive Phase 2 studies in SCAI Stage B cardiogenic shock; the SEISMiC C study in SCAI Stage C cardiogenic shock is another step progressing to the istaroxime ...

DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (NASDAQ: ABMD), a leader in breakthrough heart, lung and kidney support technologies, will feature the most recent Impella research and technological advances ...

A newly released expert consensus statement proposes a classification schema for cardiogenic shock (CS) that will facilitate communication in both the clinical and research settings. The document was ...

LAS VEGAS — In this video exclusive, Cardiology Today Editorial Board Member Timothy Henry, MD, FACC, MSCAI, Lindner Family Distinguished Chair in Clinical Research and medical director of The Carl ...

The Society for Cardiovascular Angiography and Interventions (SCAI) has released a new consensus statement on the classification of cardiogenic shock (CS). The statement, authored by a ...

WARRINGTON, Pa., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for ...

The Society for Cardiovascular Angiography and Interventions (SCAI) has refined its cardiogenic shock (CS) classification system based on the literature and clinician feedback from real-world ...

LAS VEGAS (May 19, 2019) - A newly released expert consensus statement proposes a classification schema for cardiogenic shock (CS) that will facilitate communication in both the clinical and research ...